[go: up one dir, main page]

MEP0708A - Dobijanje gama-aminokisjelina sa afinitetom za alfa-delta protein - Google Patents

Dobijanje gama-aminokisjelina sa afinitetom za alfa-delta protein

Info

Publication number
MEP0708A
MEP0708A MEP-07/08A MEP708A MEP0708A ME P0708 A MEP0708 A ME P0708A ME P708 A MEP708 A ME P708A ME P0708 A MEP0708 A ME P0708A
Authority
ME
Montenegro
Prior art keywords
alpha
amino acids
gamma
affinity
preparation
Prior art date
Application number
MEP-07/08A
Other languages
Bosnian (bs)
English (en)
Inventor
Margaret Claire Evans
Llyod Charles Franklin
Lorraine Michelle Murtagh
Thomas Norman Nanninga
Bruce Allen Pearlman
James Edward Saenz
Niamh Josephine Willis
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of MEP0708A publication Critical patent/MEP0708A/xx
Publication of ME00005B publication Critical patent/ME00005B/me

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/30Preparation of optical isomers
    • C07C227/32Preparation of optical isomers by stereospecific synthesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04Formation of amino groups in compounds containing carboxyl groups
    • C07C227/06Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/08Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to hydrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/30Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/19Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same saturated acyclic carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/002Nitriles (-CN)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/005Amino acids other than alpha- or beta amino acids, e.g. gamma amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/005Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of carboxylic acid groups in the enantiomers or the inverse reaction
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
MEP-2008-7A 2005-12-21 2006-12-11 Dobijanje gama-aminokiselina sa afinitetom za alfa-delta protein ME00005B (me)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75283905P 2005-12-21 2005-12-21
PCT/IB2006/003656 WO2007072159A1 (en) 2005-12-21 2006-12-11 Preparation of gamma-amino acids having affinity for the alpha-2-delta protein

Publications (2)

Publication Number Publication Date
MEP0708A true MEP0708A (xx) 2010-02-10
ME00005B ME00005B (me) 2010-06-10

Family

ID=37903526

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2008-7A ME00005B (me) 2005-12-21 2006-12-11 Dobijanje gama-aminokiselina sa afinitetom za alfa-delta protein

Country Status (28)

Country Link
US (2) US20070141684A1 (xx)
EP (2) EP2017259A3 (xx)
JP (1) JP2009520492A (xx)
KR (1) KR20080068932A (xx)
CN (1) CN101341117A (xx)
AP (1) AP2008004485A0 (xx)
AR (1) AR058559A1 (xx)
AU (1) AU2006327872A1 (xx)
BR (1) BRPI0620467A2 (xx)
CA (1) CA2633358A1 (xx)
CR (1) CR10080A (xx)
DO (1) DOP2006000286A (xx)
EA (1) EA200801393A1 (xx)
EC (1) ECSP088551A (xx)
GT (1) GT200600524A (xx)
IL (1) IL191840A0 (xx)
MA (1) MA30139B1 (xx)
ME (1) ME00005B (xx)
NL (1) NL2000374C2 (xx)
NO (1) NO20082989L (xx)
NZ (1) NZ568971A (xx)
PE (1) PE20071169A1 (xx)
RS (1) RS20080279A (xx)
TN (1) TNSN08272A1 (xx)
TW (1) TW200736201A (xx)
UY (1) UY30031A1 (xx)
WO (1) WO2007072159A1 (xx)
ZA (1) ZA200804780B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2294207T1 (sl) * 2008-05-21 2013-01-31 Sandoz Ag Postopek za stereoselektivno encimatsko hidrolizo estra 5-metil-3-nitrometil-heksanojske kisline
RU2528386C2 (ru) 2010-05-21 2014-09-20 Кемилиа Аб Новые производные пиримидина
FR2966734B1 (fr) * 2010-10-29 2014-07-18 Max Rombi Composition comprenant au moins une enzyme proteolytique pour son utilisation pour empecher la synthese des triglycerides
DK2688883T3 (en) 2011-03-24 2016-09-05 Noviga Res Ab pyrimidine
CN102249833B (zh) * 2011-05-27 2013-12-11 中国科学院化学研究所 一种制备手性γ-氨基酸及其衍生物的方法
WO2017155025A1 (ja) * 2016-03-10 2017-09-14 第一三共株式会社 酵素による光学分割を用いた光学活性吉草酸誘導体の製造方法
CN108192932B (zh) * 2017-12-26 2020-09-29 上海皓元生物医药科技有限公司 一种手性醇的酶催化制备方法
CN112877219A (zh) * 2021-01-29 2021-06-01 江西科技师范大学 一种高浓度胆固醇培养基及其制备方法和应用
CN119462461B (zh) * 2024-12-06 2025-11-04 万华化学集团股份有限公司 一种维生素a异构化的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5618710A (en) 1990-08-03 1997-04-08 Vertex Pharmaceuticals, Inc. Crosslinked enzyme crystals
GB9518953D0 (en) 1995-09-15 1995-11-15 Pfizer Ltd Pharmaceutical formulations
WO2000035298A1 (en) 1996-11-27 2000-06-22 Wm. Wrigley Jr. Company Chewing gum containing medicament active agents
GB9711643D0 (en) 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
US6642398B2 (en) * 1999-06-10 2003-11-04 Warner-Lambert Company Mono-and disubstituted 3-propyl gamma-aminobutyric acids
HK1046401B (zh) * 1999-06-10 2005-12-02 沃尼尔‧朗伯有限责任公司 单和双取代的3-丙基-γ-氨基丁酸
WO2004054566A1 (en) 2002-12-13 2004-07-01 Warner-Lambert Company Llc Pregabalin derivatives for the treatment of fibromyalgia and other disorders
UA82292C2 (uk) * 2004-04-14 2008-03-25 Пфайзер Продактс Инк. Спосіб стереоселективного біоперетворення аліфатичних динітрилів в ціанокарбонові кислоти (варіанти)

Also Published As

Publication number Publication date
ECSP088551A (es) 2008-07-30
TNSN08272A1 (fr) 2009-10-30
AP2008004485A0 (en) 2008-06-30
NL2000374C2 (nl) 2010-02-09
PE20071169A1 (es) 2007-11-30
EP1973867A1 (en) 2008-10-01
EA200801393A1 (ru) 2009-12-30
WO2007072159B1 (en) 2008-08-21
DOP2006000286A (es) 2007-07-31
JP2009520492A (ja) 2009-05-28
NO20082989L (no) 2008-09-19
IL191840A0 (en) 2008-12-29
MA30139B1 (fr) 2009-01-02
AR058559A1 (es) 2008-02-13
NL2000374A1 (nl) 2007-06-25
GT200600524A (es) 2007-12-03
EP2017259A3 (en) 2011-04-13
KR20080068932A (ko) 2008-07-24
CA2633358A1 (en) 2007-06-28
AU2006327872A1 (en) 2007-06-28
NZ568971A (en) 2010-04-30
US20070141684A1 (en) 2007-06-21
EP2017259A2 (en) 2009-01-21
CN101341117A (zh) 2009-01-07
WO2007072159A1 (en) 2007-06-28
ME00005B (me) 2010-06-10
BRPI0620467A2 (pt) 2011-11-16
TW200736201A (en) 2007-10-01
RS20080279A (sr) 2009-07-15
UY30031A1 (es) 2007-07-31
US20090299093A1 (en) 2009-12-03
CR10080A (es) 2008-07-10
ZA200804780B (en) 2009-05-27

Similar Documents

Publication Publication Date Title
EA200802170A1 (ru) Лиофилизированная композиция терапевтического пептидного антитела
WO2007112084A3 (en) Method to modulate hematopoietic stem cell growth
PH12013502192A1 (en) Antibodies against human angiopoietin 2
PH12015501848A1 (en) Binding agents
MX2009013970A (es) Gel de fibrina para la liberacion controlada del factor de crecimiento derivado de plaqueta (pdgf) y sus usos.
MY174493A (en) Binding agents
MX2020005214A (es) Formulaciones de anticuerpos.
WO2007112940A3 (en) Albumin-derived amino acid sequence, use thereof for increasing the half-life of therapeutic proteins and of other therapeutic compounds and entities, and constructs comprising the same
TW200642700A (en) Chemically defined stabiliser
WO2008021156A3 (en) Antibodies to il-17a
NZ592432A (en) Antibodies that specifically block the biological activity of a tumor antigen Kidney associated antigen 1 (KAAG1)
MX2011011768A (es) Composiciones y metodos de uso para moleculas de enlace a dickkopf-1 o dickkopf-4 o a ambos.
CA2705357C (en) Formulations for taci-immunoglobulin fusion proteins
WO2007130824A3 (en) Fused heterocylic compounds and their use as mglur5 modulators
NO20082989L (no) Fremstiling av gamma-aminosyrer som har affinitet for alfa-2-deltaproteinet
AR113492A2 (es) Furina recombinante libre de proteínas sustancialmente animal y métodos para producirla
WO2011069037A3 (en) Stabilization and storage of biological pharmaceutical compositions
WO2011051916A3 (en) Stabilized protein formulations and use thereof
WO2010012940A3 (fr) Forme orale microparticulaire utile pour la liberation modifiee de nanoparticules
WO2009047634A3 (en) Aqueous formulations of acetaminophen for injection
WO2007088051A3 (en) Modulation of mdl-1 activity for treatment of inflammatory disease
MX2011006721A (es) Formulacion farmaceutica de fenofibrato nanonizado.
MX2007011826A (es) Composiciones farmaceuticas de liberacion controlada de liotironina y metodos para elaborar y utilizar las mismas.
WO2009105780A3 (en) Mntf peptide compositions and methods of use
WO2009133408A3 (en) Protein formulation